advertisement
Eye and vision (London, England) 16
Showing records 1 to 16 | Display all abstracts in Eye and vision (London, England)104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Lambuk L
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Ang BCH; Chiew W
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Suhaimi NAA
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Yip VCH
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Sadikan MZ; Jafri AJA
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Chua CH; Han WS
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Ahmad S
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Tecson IOC
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Nasir NAA
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Ogle JJ
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Uskoković V
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Lim BA
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Kadir R; Mohamud R
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Hee OK
Eye and vision (London, England) 2022; 9: 27
104502 Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Mohamud R
Eye and vision (London, England) 2022; 9: 26
104553 Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma
Tay ELY; Yong VKY; Wong HT; Yip LWL
Eye and vision (London, England) 2022; 9: 27
